Purehealth said its local procurement spending has exceeded AED6.33 billion since joining the UAE’s National In-Country Value (ICV) Programme in 2022, highlighting the growing role of the healthcare sector in supporting the country’s industrial and economic diversification agenda.
The milestone was announced during Make it in the Emirates 2026, where the healthcare group outlined its progress toward a broader AED13 billion ICV commitment targeted for completion by 2032.
According to the company, the latest figure represents nearly a threefold increase from AED2.25 billion recorded in 2025, reflecting accelerated localization efforts across procurement, logistics, and operational systems.
The UAE’s National ICV Programme, led by the Ministry of Industry and Advanced Technology, is designed to redirect procurement spending into the domestic economy by strengthening local manufacturing, supplier networks, workforce development, and industrial capacity.
PureHealth said its ICV strategy is being implemented across multiple entities within its healthcare ecosystem, including SEHA, Sheikh Shakhbout Medical City, Daman, PureLab, and Rafed.
Among the group’s entities, SEHA recorded an ICV score of 81.13 percent, reflecting the integration of local sourcing and workforce development initiatives across operations.
Rashed AlQubaisi said the ICV strategy has become central to the group’s long-term operational model.
“By consistently prioritizing local capability, we are strengthening supply chain resilience, safeguarding continuity of care, and aligning with the UAE’s industrial agenda while contributing to long-term economic growth and diversification,” he said.
The announcement underscores the increasing role of healthcare providers in the UAE’s broader industrial strategy, particularly as the country seeks to localize critical supply chains and reduce dependency on imported medical products and services.
The COVID-19 pandemic accelerated global focus on healthcare supply chain resilience, prompting governments and healthcare groups to invest more heavily in domestic production, procurement diversification, and localized logistics capabilities.
PureHealth’s efforts have also received recognition under the ICV framework. In 2026, SEHA received the ICV Champion Award at Make it in the Emirates, while Rafed received similar recognition in 2025 for supporting SME participation through the programme.
Daman also received multiple awards from the federal Emiratisation initiative, Nafis, for its efforts related to workforce development and national talent empowerment.
The healthcare group’s expanding procurement activity reflects a broader trend across the UAE economy, where both public and private sector entities are increasingly embedding ICV requirements into procurement frameworks, supplier selection, and operational planning.
The development also highlights how the UAE’s industrial policy is extending beyond traditional sectors such as manufacturing and energy into healthcare, logistics, pharmaceuticals, and advanced services.
With Inputs WAM
